SEO URLwww.firestrike.ai/deals/orna-therapeutics-lilly-acquisition-2026-3

acquisitionAnnounced · Feb 9, 2026biotechnologySource · CredibleArticle · Factual

Orna Therapeutics · Lilly

Lilly acquires Orna Therapeutics

David Najork · Founding Software Engineer

Announced Feb 9, 2026 · Updated Apr 29, 2026 · 1 min read

ShareX LinkedIn Email

Deal value

$2.4B

Target

Orna Therapeutics

Cambridge, Massachusetts

Acquirer

Lilly

Full Acquisition

Status

Announced

Lilly agreed to acquire Orna Therapeutics. Reported deal value: $2.4B. Status: Announced. Sector: biotechnology. Target headquarters context: Cambridge, Massachusetts, United States.

This page summarizes publicly available information about the transaction as of 2026-02-09. Figures and status may change as filings and press coverage update.

Eli Lilly and Company to acquire Orna Therapeutics 39 seconds ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 50 minutes ago Earnings Summary: Highlights of Apollo Global Management Q4 FY25 report 2 hours ago Plains All American weakens as NGL divestiture and cost cuts frame muted 2026 growth 4 hours ago Plains All American Streamlines, Targets Crude Growth Amid NGL Exit 4 hours ago Operational Efficiency Powers MGY to Historic Production and Dividend Lift 5 hours ago Johnson Outdoors Hooks 31% Revenue Gain, Operating Loss Narrows 5 hours ago Innova...

Deal timeline

Announced

Feb 9, 2026 · news.alphastreet.com

Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.

Sector context

This transaction is classified in biotechnology with a reported deal value of $2.4B. Figures and status may change as sources update.

Sources: news.alphastreet.com · Primary article · FireStrike proprietary index